Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.
Therapy-related acute leukemia (t-AML), is a severe complication of cytotoxic therapy used for primary cancer treatment. The outcome of these patients is poor, compared to people who develop de novo acute leukemia (p-AML). Cytogenetic abnormalities in t-AML are similar to those found in p-AML but pr...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/38591c1fa04a49b389de4c12cc74c108 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:38591c1fa04a49b389de4c12cc74c108 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:38591c1fa04a49b389de4c12cc74c1082021-11-18T06:58:51ZChromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.1932-620310.1371/journal.pone.0016623https://doaj.org/article/38591c1fa04a49b389de4c12cc74c1082011-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21339820/?tool=EBIhttps://doaj.org/toc/1932-6203Therapy-related acute leukemia (t-AML), is a severe complication of cytotoxic therapy used for primary cancer treatment. The outcome of these patients is poor, compared to people who develop de novo acute leukemia (p-AML). Cytogenetic abnormalities in t-AML are similar to those found in p-AML but present more frequent unfavorable karyotypes depending on the inducting agent. Losses of chromosome 5 or 7 are observed after alkylating agents while balanced translocations are found after topoisomerase II inhibitors. This study compared t-AML to p-AML using high resolution array CGH in order to find copy number abnormalities (CNA) at a higher resolution than conventional cytogenetics. More CNAs were observed in 30 t-AML than in 36 p-AML: 104 CNAs were observed with 63 losses and 41 gains (mean number 3.46 per case) in t-AML, while in p-AML, 69 CNAs were observed with 32 losses and 37 gains (mean number of 1.9 per case). In primary leukemia with a previously "normal" karyotype, 18% exhibited a previously undetected CNA, whereas in the (few) t-AML with a normal karyotype, the rate was 50%. Several minimal critical regions (MCRs) were found in t-AML and p-AML. No common MCRs were found in the two groups. In t-AML a 40 kb deleted MCR pointed to RUNX1 on 21q22, a gene coding for a transcription factor implicated in frequent rearrangements in leukemia and in familial thrombocytopenia. In de novo AML, a 1 Mb MCR harboring ERG and ETS2 was observed from patients with complex aCGH profiles. High resolution cytogenomics obtained by aCGH and similar techniques already published allowed us to characterize numerous non random chromosome abnormalities. This work supports the hypothesis that they can be classified into several categories: abnormalities common to all AML; those more frequently found in t-AML and those specifically found in p-AML.Nathalie ItzharPhilippe DessenSaloua ToujaniNathalie AugerClaude PreudhommeCatherine RichonVladimir LazarVéronique SaadaAnelyse BennaceurJean Henri BourhisStéphane de BottonAlain BernheimPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 2, p e16623 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Nathalie Itzhar Philippe Dessen Saloua Toujani Nathalie Auger Claude Preudhomme Catherine Richon Vladimir Lazar Véronique Saada Anelyse Bennaceur Jean Henri Bourhis Stéphane de Botton Alain Bernheim Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH. |
| description |
Therapy-related acute leukemia (t-AML), is a severe complication of cytotoxic therapy used for primary cancer treatment. The outcome of these patients is poor, compared to people who develop de novo acute leukemia (p-AML). Cytogenetic abnormalities in t-AML are similar to those found in p-AML but present more frequent unfavorable karyotypes depending on the inducting agent. Losses of chromosome 5 or 7 are observed after alkylating agents while balanced translocations are found after topoisomerase II inhibitors. This study compared t-AML to p-AML using high resolution array CGH in order to find copy number abnormalities (CNA) at a higher resolution than conventional cytogenetics. More CNAs were observed in 30 t-AML than in 36 p-AML: 104 CNAs were observed with 63 losses and 41 gains (mean number 3.46 per case) in t-AML, while in p-AML, 69 CNAs were observed with 32 losses and 37 gains (mean number of 1.9 per case). In primary leukemia with a previously "normal" karyotype, 18% exhibited a previously undetected CNA, whereas in the (few) t-AML with a normal karyotype, the rate was 50%. Several minimal critical regions (MCRs) were found in t-AML and p-AML. No common MCRs were found in the two groups. In t-AML a 40 kb deleted MCR pointed to RUNX1 on 21q22, a gene coding for a transcription factor implicated in frequent rearrangements in leukemia and in familial thrombocytopenia. In de novo AML, a 1 Mb MCR harboring ERG and ETS2 was observed from patients with complex aCGH profiles. High resolution cytogenomics obtained by aCGH and similar techniques already published allowed us to characterize numerous non random chromosome abnormalities. This work supports the hypothesis that they can be classified into several categories: abnormalities common to all AML; those more frequently found in t-AML and those specifically found in p-AML. |
| format |
article |
| author |
Nathalie Itzhar Philippe Dessen Saloua Toujani Nathalie Auger Claude Preudhomme Catherine Richon Vladimir Lazar Véronique Saada Anelyse Bennaceur Jean Henri Bourhis Stéphane de Botton Alain Bernheim |
| author_facet |
Nathalie Itzhar Philippe Dessen Saloua Toujani Nathalie Auger Claude Preudhomme Catherine Richon Vladimir Lazar Véronique Saada Anelyse Bennaceur Jean Henri Bourhis Stéphane de Botton Alain Bernheim |
| author_sort |
Nathalie Itzhar |
| title |
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH. |
| title_short |
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH. |
| title_full |
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH. |
| title_fullStr |
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH. |
| title_full_unstemmed |
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH. |
| title_sort |
chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution acgh. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/38591c1fa04a49b389de4c12cc74c108 |
| work_keys_str_mv |
AT nathalieitzhar chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT philippedessen chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT salouatoujani chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT nathalieauger chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT claudepreudhomme chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT catherinerichon chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT vladimirlazar chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT veroniquesaada chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT anelysebennaceur chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT jeanhenribourhis chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT stephanedebotton chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh AT alainbernheim chromosomalminimalcriticalregionsintherapyrelatedleukemiaappeardifferentfromthoseofdenovoleukemiabyhighresolutionacgh |
| _version_ |
1718424095016615936 |